AlzeCure Pharma (ALZCUR ST) stock market data APIs
kr2.0894
0.04(1.9%)
as of December 15, 2025
Try our APIs with
free plan!
AlzeCure Pharma Financial Data Overview
Price chart is built with
Anychart
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer's disease, sleep disorders, depression, traumatic brain injuries, and Parkinson's disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
Prev. Close
2.0894
Open
2.1274
High
2.1378
Low
2.0263
52 wk Range
0.812-4.95
Market Cap
241 M
Shares Outstanding
115 M
Revenue
-74 000
EPS
-0.0907
Beta
-0.078
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get AlzeCure Pharma data using free add-ons & libraries
Get AlzeCure Pharma Fundamental Data
AlzeCure Pharma Fundamental data includes:
- Net Revenue: -74 000
- EBITDA: -39 596 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
AlzeCure Pharma News
New
AlzeCure Appoints Cecilia Wadell as New Head of Development
STOCKHOLM, SE / ACCESS Newswire / August 20, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusin...
3 European Penny Stocks With Market Caps Under €30M
As European markets navigate a landscape of mixed stock index performances and economic shifts, investors are keeping a close eye on potential opportunities in lesser-known sectors. Penny stocks, thou...
AlzeCure’s Rights Issue is Registered and the Trading in Paid Subscription Shares Ceases
STOCKHOLM, SE / ACCESSWIRE / April 13, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) has completed a rights issue of shares that closed on March 22, 2022. The rights issue i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
